Higher Preoperative Endometrial Cancer Risk Showed More Advanced Stage

Preoperative Lymphedema-Related Risk Factors in Early-Stage Breast Cancer.

BACKGROUND Prolongation of survival in patients with breast cancer due to early diagnosis and modern methods of treatment has turned the attention on lymphedema, which is the most important morbidity secondary to the treatment of the disease. Determination of lymphedema and related risk factors in patients before a surgical intervention may provide protection for patients and early treatment. T...

Preoperative Pet–ct in Endometrial Cancer

Fewer than 20% of women with endometrial cancer have positive nodes, and an accurate noninvasive imaging modality to assess lymph node status would be helpful in selecting those who need lymphadenectomy. The objective of this pilot study was to evaluate positron emission tomography with computed tomography (PET–CT) in predicting nodal status before surgery for endometrial cancer. Twelve patient...

Management of Early Stage, High-Risk Endometrial Carcinoma: Preoperative and Surgical Considerations

Endometrial cancer is the most common gynecologic malignancy in the developed world. Most cases are diagnosed at an early stage and have low-grade histology, portending an overall excellent prognosis. There exists a subgroup of patients with early, high-risk disease, whose management remains controversial, as current data is clouded by inclusion of early stage tumors with different high-risk fe...

Relation of Preoperative Thrombocytosis between Tumor Stage and Grade in Patients with Endometrial Cancer.

OBJECTIVE We aimed to evaluate the predictive value of preoperative thrombocytosis for postoperative tumor stage and tumor grade in patients with endometrial cancer. MATERIALS AND METHODS This was a retrospective study carried out in our gynecologic oncology department between January 2000 and December 2011. We reviewed the medical charts of 190 patients diagnosed with endometrial carcinoma a...

Adjuvant Management of Early Stage Endometrial Cancer